Could modified venom from the Peruvian green velvet tarantula help end the opiod epidemic?

The new technology, which translates signals from the brain, could lead to more natural communication for people who have suffered speech loss.

As private citizens express interest in going to space, a late UCSF astronaut may have figured out an important riddle.

Experts share their thoughts about the SARS-CoV-2 variant, which is now in nearly every state.

Strauss Foundation scholar Joseph Bello focuses on getting people the wheelchairs they need, faster.

Why are some of us insomniacs and others “super sleepers”? Researchers are finding answers in our genes.

The nation is in the midst of a blood shortage – considering making a donation.

The hard part was everything that came next, says UCSF alum Stephen Hoge, president of Moderna.

A $3M National Institutes of Health grant to three UC campuses will seek to improve survival rates for patients on dialysis.

Researchers have identified a predictive causal role for specific cell types in the condition, which affects more than 1.6 million Americans.

Ronke Olabisi is working on a cell regenerative therapy with potential applications in chronic wounds, burns and aging.

Researchers have demonstrated how to engineer smart immune cells that are effective against solid tumors.